COS in Medical News

Pharma cos must forge Strategic alliances

Indian pharmaceutical majors should go in for strategic alliances among themselves to capture export markets increasingly by leveraging cost advantages and precluding cut-throat competition which would be detrimental to the industry. This was stated by the Commerce Secretary, Mr. Prabir Sengupta...

Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos

A NOVEL research-cum-manufacturing agreement between Chiron Corp, the US-based vaccine major, and an Indian company for the development of a potential AIDS vaccine to halt the spread of the deadly disease in the country is in an advanced stage of finalisation. Two Hyderabad-based biotechnology...

New Report Just Published: World Hepatitis C Virus And Therapeutics Market Report

...ases Phase II Findings of IC41 II-61 6. Recent Industry Activity II-62 Three Rivers Acquires Infergen(R) II-62 International Consolidated cos Takes Over China Gene II-62 Hologic Signs Definitive Deal to Acquire Third Wave II-62 GlaxoSmithKline Inks Deal to Take Over Genelabs II-62 ...

Schering-Plough Announces European Submission of Fertility Medicine Corifollitropin Alfa

...gle subcutaneous injection of the recommended dose of corifollitropin alfa may replace the first seven injections of (recombinant)FSH preparation in a cos treatment cycle. If approved, corifollitropin alfa would extend Schering-Plough's leading fertility portfolio, which also includes PUREGON(R). ...

Huifeng Bio-Pharmaceutical (HFGB) Reports Record Sales and Net Income

...and L-Rhamnose continue to drive sales. "We are very excited about the results of the third quarter and hope to build upon them going forward. cos approval is expected in the near future, allowing us to begin sales of Diosmin to our strategic partner Safic-Alcan of France. We are entering a very ...

War Veterans With Traumatic Brain Injury Pay the Price of Waste at the VA, Says Dr. Robert Van Boven

...penditures." The Chief of Staff (COS) at CTVHCS testified that he was clearly aware of these disclosures, yet he failed to act. At a VA hearing, the cos stated that Dr. Van Boven "expressed concern that [an investigator's] research was ill-conceived, and he [the investigator] was making excessive use o...

CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecom's IP VPN

...r. "And their class of service (CoS) technology is much easier and more flexible to implement than other providers, while being very cost competitive. cos was a key technical requirement in being able to consolidate our IT infrastructure." The full backing of service level agreements (SLAs) was an addi...